Skip to main content

Gennev is covered by insurance companies. Check if you are in network now.

Dementia is a major concern for many women considering hormone therapy. This webinar will review the evidence linking MHT to neurologic outcomes, including where findings conflict and how timing and formulation may matter. We’ll explore strategies for counseling women who are fearful of cognitive decline while balancing individual risk factors and available data.